Retrospective Evaluation of Thromboembolism Risk in Ovarian Cancer Patients Treated with Bevacizumab

BACKGROUND: Bevacizumab is used in addition to standard, platinum-based chemotherapy to treat advanced-stage ovarian cancer patients. Thrombosis is a well-documented adverse effect of bevacizumab. OBJECTIVE: The aim of this study was to identify predictive parameters for thromboembolic events in ova...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuk, Anna, Magnowska, Magdalena, Suchy, Wiktor, Swierczynska, Joanna, Zaborowski, Mikolaj Piotr, Gaca, Michal, Nowak-Markwitz, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524869/
https://www.ncbi.nlm.nih.gov/pubmed/28580507
http://dx.doi.org/10.1007/s11523-017-0496-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524869/
https://www.ncbi.nlm.nih.gov/pubmed/28580507
http://dx.doi.org/10.1007/s11523-017-0496-3

Ejemplares similares